Document Detail

Cell microencapsulation technology for biomedical purposes: novel insights and challenges.
MedLine Citation:
PMID:  12767713     Owner:  NLM     Status:  MEDLINE    
The aim of cell microencapsulation technology is to treat multiple diseases in the absence of immunosuppression. Using this technique, cells are immobilized within carefully designed capsules that allow the long-term function of the graft. Although the potential impact of this field is likely to be wide-ranging, the past few years have seen several 'firsts' that have brought the whole technology much closer to a realistic clinical application.
Gorka Orive; Alicia R Gascón; Rosa M Hernández; Manuela Igartua; José Luis Pedraz
Related Documents :
11197673 - Analysis of the influence of the cell geometry, orientation and cell proximity effects ...
19438193 - High open-circuit voltage solid-state dye-sensitized solar cells with organic dye.
3061583 - The origin of cell-type differences in early embryos.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Trends in pharmacological sciences     Volume:  24     ISSN:  0165-6147     ISO Abbreviation:  Trends Pharmacol. Sci.     Publication Date:  2003 May 
Date Detail:
Created Date:  2003-05-27     Completed Date:  2003-08-04     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7906158     Medline TA:  Trends Pharmacol Sci     Country:  England    
Other Details:
Languages:  eng     Pagination:  207-10     Citation Subset:  IM    
Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country, Vitoria-Gasteiz, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cell Adhesion / drug effects,  immunology
Cell Transplantation / methods*,  physiology
Drug Delivery Systems / methods*
Immunosuppression / methods
Technology, Pharmaceutical / methods*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Complex dispersions of multilamellar vesicles: a promising new carrier for controlled release and pr...
Next Document:  Can a proteomics strategy be used to identify the anti-malarial activity of chloroquine?